In vivo Glioblastoma Therapy Using Targeted Liposomal Cisplatin
Maryam Sadat Ashrafzadeh,1 Azim Akbarzadeh,2 Amir Heydarinasab,1 Mehdi Ardjmand3 1Department of Chemical Engineering, Science and Research Branch, Islamic Azad University, Tehran, Iran; 2Department of Pilot Nanobiotechnology, Pasteur Institute of Iran, Tehran, Iran; 3Department of Chemical Engineeri...
Enregistré dans:
Auteurs principaux: | Ashrafzadeh MS, Akbarzadeh A, Heydarinasab A, Ardjmand M |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/10b51f40146f49a09d9fc752cb0a061b |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Liposome based drug delivery as a potential treatment option for Alzheimer’s disease
par: Carely Hernandez, et autres
Publié: (2022) -
Nanoparticle-Guided Brain Drug Delivery: Expanding the Therapeutic Approach to Neurodegenerative Diseases
par: Claudia Riccardi, et autres
Publié: (2021) -
The functional curcumin liposomes induce apoptosis in C6 glioblastoma cells and C6 glioblastoma stem cells in vitro and in animals
par: Wang YH, et autres
Publié: (2017) -
Efficient Anti-Glioma Therapy Through the Brain-Targeted RVG15-Modified Liposomes Loading Paclitaxel-Cholesterol Complex
par: Xin X, et autres
Publié: (2021) -
Nanotherapeutics Overcoming the Blood-Brain Barrier for Glioblastoma Treatment
par: Lin Tang, et autres
Publié: (2021)